Intestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imaging

Alimentary Pharmacology and Therapeutics

Volumn 22, Issue 10, 2005, Pages 971-979

  Schiller, C ^a   Frohlich C P ^a   Giessmann, T ^a   Siegmund, W ^a   Monnikes H ^b   Hosten, N ^a   Weitschies, W ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COLON; DIET RESTRICTION; DRUG ABSORPTION; FEMALE; FOOD INTAKE; HUMAN; HUMAN EXPERIMENT; ILEOCECAL VALVE; INTESTINE; INTESTINE FLUID; MALE; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

ADULT; BODY WATER; CAPSULES; COLON; FEMALE; GASTROINTESTINAL TRANSIT; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED;

EID: 27744515754     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2005.02683.x     Document Type: Article

References (21)

1. Kimura T, Higaki K. Gastrointestinal transit and drug absorption. Biol Pharm Bull 2002; 25: 149-64.
2. Martinez MN, Amidon GL. A mechanistic approach to understanding the factors affecting drug absorption: a review of fundamentals. J Clin Pharmacol 2002; 42: 620-43.
3. Lomas DJ, Graves MJ. Small bowel MRI using water as a contrast medium. Br J Radiol 1999; 72: 994-7.
4. Dietrich CG, Geier A, Oude Elferink RP. ABC of oral bioavailability: transporters as gatekeepers in the gut. Gut 2003; 52: 1788-95.
5. Chan LM, Lowes S, Hirst BH. The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability. Eur J Pharm Sci 2004; 21: 25-51.
6. Wilding IR, Hardy JG, Sparrow RA, Davis SS, Daly PB, English JR. In vivo evaluation of enteric-coated naproxen tablets using gamma scintigraphy. Pharm Res 1992; 9: 1436-41.
7. Riad LE, Sawchuk RJ, McAlary MM, Chan KK. Effect of food on the multiple-peak behavior after a single oral dose of diclofenac sodium slow-release tablet in humans. Am J Ther 1995; 2: 237-42.
8. Ozturk SS, Palsson BO, Donohoe B, Dressman JB. Kinetics of release from enteric-coated tablets. Pharm Res 1988; 5: 550-65.
9. Matsuzaki T, Tajika Y, Ablimit A, Aoki T, Hagiwara H, Takata K. Aquaporins in the digestive system. Med Electron Microsc 2004; 37: 71-80.
10. Mobasheri A, Shakibaei M, Marples D. Immunohistochemical localization of aquaporin 10 in the apical membranes of the human ileum: a potential pathway for luminal water and small solute absorption. Histochem Cell Biol 2004; 121: 463-71.
11. Loo DD, Wright EM, Zeuthen T. Water pumps. J Physiol 2002; 542: 53-60.
12. King LS, Lozono D, Agre P. From structure to disease: the evolving tale of aquaporin biology. Nat Rev Mol Cell Biol 2004; 5: 687-98.
13. Camilleri M, Colemont LJ, Phillips SF, et al. Human gastric emptying and colonic filling of solids characterized by a new method. Am J Physiol 1989; 257: G284-90.
14. Spiller RC, Brown ML, Phillips SF. Emptying of the terminal ileum in intact humans. Influence of meal residue and ileal motility. Gastroenterology 1987; 92: 724-9.
15. Quigley EM, Borody TJ, Phillips SF, Wienbeck M, Tucker RL, Haddad A. Motility of the terminal ileum and ileocecal sphincter in healthy humans. Gastroenterology 1984; 87: 857-66.
16. Shafik A, El-Sibai O, Shaflk Ali A. Physiological assessment of the function of the ileocecal junction with evidence of ileocecal junction reflexes. Med Sci Monit 2002; 8: CR629-35.
17. Palma R, Vidon N, Bernier JJ. Maximal capacity for fluid absorption in human bowel. Dig Dis Sci 1981; 26: 929-34.
18. Leiper JB. Intestinal water absorption. Implications for the formulation of rehydration solutions. Int J Sports Med 1998; 19 (Suppl. 2): 129-32.
19. Borgstrom B, Dahlqvist A, Lundh G, Sjovall J. Studies of intestinal digestion and absorption in the human. J Clin Invest 1957: 36: 1521-36.
20. Ezzet F, Krishna G, Wexler DB, Statkevich P, Kosoglou T, Batra VK. A population pharmacokinetic model that describes multiple peaks due to enterohepatic recirculation of ezetimibe. Clin Ther 2001; 23: 871-85.
21. De Mey C, Meineke I. Prandial and diurnal effects on the absorption of orally administered enteric coated 5-aminosalicylic acid (5-ASA). Br J Clin Pharmacol 1992; 33: 179-82.